Training, Protocol Increase Use of Developmental Screening Tools

2007 ◽  
Vol 41 (8) ◽  
pp. 28
Author(s):  
KATE JOHNSON
2018 ◽  
Vol 23 (suppl_1) ◽  
pp. e37-e37
Author(s):  
Vinusha Gunaseelan ◽  
Patricia Parkin ◽  
Imaan Bayoumi ◽  
Patricia Jiang ◽  
Alexandra Medline ◽  
...  

Abstract BACKGROUND The Canadian Paediatric Society (CPS) recommends that every Canadian physician caring for young children provide an enhanced 18-month well-baby visit including the use of a developmental screening tool, such as the Nipissing District Developmental Screen (NDDS). The Province of Ontario implemented an enhanced 18-month well-baby visit specifically emphasizing the NDDS, which is now widely used in Ontario primary care. However, the diagnostic accuracy of the NDDS in identifying early developmental delays in real-world clinical settings is unknown. OBJECTIVES To assess the predictive validity of the NDDS in primary care for identifying developmental delay and prompting a specialist referral at the 18-month health supervision visit. DESIGN/METHODS This was a prospective longitudinal cohort study enrolling healthy children from primary care practices. Parents completed the 18-month NDDS during their child’s scheduled health supervision visit between January 2012 and February 2015. Using a standardized data collection form, research personnel abstracted data from the child’s health records regarding the child’s developmental outcomes following the 18-month assessment. Data collected included confirmed diagnoses of a development delay, specialist referrals, family history, and interventions. Research personnel were blind to the results of the NDDS. We assessed the diagnostic test properties of the NDDS with a confirmed diagnosis of developmental delay as the criterion measure. The specificity, sensitivity, positive predictive value, and negative predictive value were calculated, with 95% confidence intervals. RESULTS We included 255 children with a mean age of 18.5 months (range, 17.5–20.6) and 139 (55%) were male. 102 (40%) screened positive (1+ flag result on their NDDS). A total of 48 (19%) children were referred, and 23 (9%) had a confirmed diagnosis of a developmental delay (speech and language: 14; gross motor: 4; autism spectrum disorder: 3; global developmental delay: 1; developmental delay: 1). The sensitivity was 74% (95% CI: 52–90%), specificity was 63% (95% CI: 57–70%), positive predictive value was 17% (95% CI:10–25%), and the negative predictive value was 96% (95% CI: 92–99%). CONCLUSION For developmental screening tools, sensitivity between 70%-80% and specificity of 80% have been suggested. The NDDS has moderate sensitivity and specificity in identifying developmental delay at the 18-month health supervision visit. The 1+NDDS flag cut-point may lead to overdiagnosis with more children with typical development being referred, leading to longer wait times for specialist referrals among children in need. Future work includes investigating the diagnostic accuracy of combining the NDDS with other screening tools.


2017 ◽  
Vol 27 (8) ◽  
pp. 1447-1454 ◽  
Author(s):  
Maia M. Noeder ◽  
Beth A. Logan ◽  
Kari L. Struemph ◽  
Nancy Condon ◽  
Isabel Mueller ◽  
...  

AbstractObjectiveStandardised developmental screening tools are important for the evaluation and management of developmental disorders in children with CHD; however, psychometric properties and clinical utility of screening tools, such as the Ages & Stages Questionnaires, Third Edition (ASQ-3), have not been examined in the CHD population. We hypothesised that the ASQ-3 would be clinically useful for this population.Study designASQ-3 developmental classifications for 163 children with CHD at 6, 12, 24, and/or 36 months of age were compared with those obtained from concurrent developmental testing with the Bayley Scales of Infant and Toddler Development, Third Edition.ResultsWhen ASQ-3 screening failure was defined as ⩾1 SD below the normative mean, specificity (⩾81.9%) and negative predictive value (⩾81.0%) were high across ASQ-3 areas. Sensitivity was high for gross motor skills (79.6%), increased with age for communication (35.7–100%), and generally decreased with age for problem solving (73.1–50.0%). When ASQ-3 screening failure was defined as ⩾2 SD below the normative mean, specificity (⩾93.6%) and positive predictive value (⩾74.5%) were generally high across ASQ-3 areas, but sensitivity was low (31.1%) to fair (62.8%). The ASQ-3 showed improved accuracy in predicting delays over clinical risk factors alone.ConclusionsThe ASQ-3 appears to be a clinically useful tool for screening development in children with CHD, although its utility varied on the basis of developmental area and time point. Clinicians are encouraged to refer children scoring ⩾1 SD below the normative mean on any ASQ-3 area for formal developmental evaluation.


2008 ◽  
Vol 93 (1) ◽  
pp. 23-29 ◽  
Author(s):  
M J Gladstone ◽  
G A Lancaster ◽  
A P Jones ◽  
K Maleta ◽  
E Mtitimila ◽  
...  

1980 ◽  
Vol 5 (2) ◽  
pp. 126???130
Author(s):  
MARY O??PRAY ◽  
M S. O??PRAY

2020 ◽  
Author(s):  
Ali M. El Shafie ◽  
Zein A.L. Omar ◽  
Mai M. Bashir ◽  
sorour fayez mahmoud ◽  
El-sayedamr M. Basma ◽  
...  

Abstract Background: Detecting developmental delays in infants is an ongoing world commitment, especially for those below three years old. it provides appropriate services to them, early inspection enhances the communal quality of resolving difficult issues of this critical period of age. Thus, our main objective lies in developing a sufficient screening test for early evaluation of mental and motor development for infants.Methods: 54 items of motor and mental developmental milestones were adopted from the Baroda Screening Test. Then, researchers enrolled 1600 subjects based on certain inclusion and exclusion criteria. 97 pass level of developmental achievements resembles the threshold of which infants below which, infants are considered delayed.Results: The designed Egyptian Developmental Screening Tool (“EDST”) from birth up to 30 monthswith 50% and 97% pass level curves proves efficacy, reliability, cultural adaptability, and simplicity to use when compared with other peer screening tools. Results revealed a statistically significant difference between Egyptian and Baroda chart at 50% and 97% pass level. A z-score chart for motor and mental development follow up designed by calculating each age group.Conclusions: Developmental screening tests from birth up to 30 months proved consistent reliability and versatility to use in Egypt for early development delay detection. The wide variation of Egyptian infants 'developmental ages on both Egyptian and Baroda charts underpins the Egyptian chart to the Egyptian public. The z-score chart is a rapid and easy follow-up chart for Egyptian infants' development.


2016 ◽  
Vol 35 (2) ◽  
pp. 162-167 ◽  
Author(s):  
Selvam Ramachandran ◽  
Sudip Dutta

The preterm very low birth weight infants are at high risk of motor developmental delays. The developmental screening tools used by health professionals in pediatric practice serves several purposes viz. as a discriminative screening tool to identify the developmental delay in such high risk infants; as an evaluation tool to quantify the levels of functional skills achieved; as a prognostic tool to quantify the changes in levels of functional skills following specific developmental care interventions and as a predictive tool to predict the quantum of existing or impending neuro-developmental disability in high risk infants. Thus developmental screening tools serves as an integral part of early intervention programs. Such screening tools also serve as program evaluation strategy in quantifying the efficacy of early developmental care intervention programs. This review is aimed at describing the properties of developmental screening tools for motor developmental delay in preterm infants.J Nepal Paediatr Soc 2015;35(2):162-167


2018 ◽  
Vol 23 (suppl_1) ◽  
pp. e51-e52
Author(s):  
Madelyn Barton ◽  
Marie-Noëlle Simard ◽  
Sandra Reiter-Campeau ◽  
Genevieve Lupien ◽  
Marie-Pierre Lamothe ◽  
...  

Abstract BACKGROUND Infants with childhood-onset epilepsies, including epileptic encephalopathies, are at high risk of developmental challenges such as motor and language delays. There has been a growing focus on developmental screening instruments due to the association between delayed development and long-term adverse outcomes, including negative impacts on health-related quality of life, school achievement and social participation. Therefore, children with developmental delays should be referred as early as possible to rehabilitation services such as occupational, physical, or speech therapy. Developmental screening using standardized tools is recommended in order to identify the high-risk children that require additional developmental assessments. The Ages and Stages Questionnaires (ASQ), a parent-completed developmental screening tool, is one of the more cited and recommended developmental screening tools. However, its utility in children with early-onset epilepsy has yet to be validated. OBJECTIVES This study aimed to determine the validity of the ASQ for identifying children with new-onset epilepsy who require further professional developmental rehabilitation. DESIGN/METHODS Fifty infants (25 males) with seizure onset under 3 years of age were prospectively recruited. Parents completed the ASQ-3 before the first clinic appointment. The ASQ-3 evaluates 5 domains of development. An ASQ score below 2 standard deviations (SD) on any one of the domains was considered abnormal. Once completed, all infants were evaluated by a multidisciplinary team including neurologists, occupational therapists, and physical therapists to determine if they should be referred for further rehabilitation interventions. Accuracy of the ASQ was calculated in terms of sensibility, specificity, positive predictive value (PPV) and negative predictive value (NPV). RESULTS Mean age at the initial evaluation was 13.1 months (SD=8.22). Among the 50 infants, 36 (72%) received a score <-2 SD in at least one domain of the ASQ and 43 (86%) were referred for further rehabilitation services after the multidisciplinary assessment. The ASQ had a sensitivity of 81%, a specificity of 71%, a PPV of 93% and a NPV of 36% in identifying children with new-onset epilepsy who would require further rehabilitation services. CONCLUSION The ASQ, a well-known parent-completed developmental screening tool, when abnormal shows adequate validity for the identification of children with early-onset epilepsy who require developmental assessments and interventions by rehabilitation professionals. Our results also provide further evidence that development delay is the rule rather than the exception in infants with new onset epilepsy.


2018 ◽  
Author(s):  
Andrew Miller ◽  
Katie Swec ◽  
Sarah Watkins ◽  
Elizabeth Chen ◽  
Alison Paul ◽  
...  

BACKGROUND Clinical care guidelines for universal developmental screening are meant to identify at-risk children as early as possible so that early intervention can be initiated. However, despite years of initiatives, developmental screening rates remain less than ideal. Recent innovations in mHealth apps that integrate developmental screening may offer an alternate way to optimize screening rates if it can encourage co-use and seamless integration into clinical workflow. OBJECTIVE Prior to the planned deployment of a clinic-based mHealth developmental screening app, the research team sought to identify and characterize opportunities and challenges to implementation, focusing on clinic workflow and multi-stakeholder engagement with providers and parents. METHODS Three clinic settings were recruited to participate from one children’s hospital in Indianapolis, Indiana. Preimplementation clinical observations of workflow and team dynamics were performed. Potential adoption barriers and facilitators were explored through interviews with health care teams guided by the Consolidated Framework for Implementation Research (CFIR). Parents with children aged 0-5 were recruited from study clinics and social media to complete a 26-item survey to gauge their attitudes towards using apps in place of paper screening forms and for tracking their child’s development. RESULTS Proposed implementation workflows were co-created with each clinical team so to not increase overall visit length, which was the main concern for health care providers. Providers had enthusiasm for use of mHealth tools; however, concerns were expressed about potential technology failures, data security and HIPAA and the workflow impacts. Two hundred fifty parents responded to the social media survey. The top reason for downloading child health apps were for a convenient way to track development (62.6%). Two-thirds of respondents expressed interest in an app that included developmental screening forms. Most parents prefer to complete screening tools on the day of the clinic visit (47.7%) or electronically prior to the visit (44.8%). Seventy-four percent of parents expressed a higher likelihood of using an app if recommended by the pediatrician. CONCLUSIONS Parents and providers are interested and open to mHealth apps for child developmental screening. Provider buy-in and involvement in implementation planning is critical, both to integrating apps into clinic workflows and to encouraging parents to use the app.


Sign in / Sign up

Export Citation Format

Share Document